1. |
Wang CJ, Huang CC, Wang JW, et al. Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight-to nine-year follow-up. Biomed J, 2012, 35(6):481-485.
|
2. |
Issa K, Pivec R, Kapadia BH, et al. Osteonecrosis of the femoral head:the total hip replacement solution. Bone Joint J, 2013, 95-B(11 Suppl A):46-50.
|
3. |
Zhao FC, Li ZR, Guo KJ. Clinical analysis of osteonecrosis of the femoral head induced by steroids. Orthop Surg, 2012, 4(1):28-34.
|
4. |
Jones JP Jr. Concepts of etiology and early pathogenesis of osteonecrosis. Instr Course Lect, 1994, 43:499-512.
|
5. |
Nakamura J, Ohtori S, Watanabe A, et al. Recovery of the blood flow around the femoral head during early corticosteroid therapy:dynamic magnetic resonance imaging in systemic lupus erythematosus patients. Lupus, 2012, 21(3):264-270.
|
6. |
Paydas S, Balal M, Demir E, et al. Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients. Transplant Proc, 2011, 43(3):863-866.
|
7. |
Motomura G, Yamamoto T, Miyanishi K, et al. Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol, 2008, 35(12):2391-2394.
|
8. |
Chauhan V, Ranganna KM, Chauhan N, et al. Bone disease in organ transplant patients:pathogenesis and management. Postgrad Med, 2012, 124(3):80-90.
|
9. |
Erken HY, Ofluoglu O, Aktas M, et al. Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head:experimental study in chicken. Int Orthop, 2012, 36(7):1523-1528.
|
10. |
Ragni E, Montemurro T, Montelatici E, et al. Differential microRNA signature of human mesenchymal stem cells from different sources reveals an "environmental-niche memory" for bone marrow stem cells. Exp Cell Res, 2013, 319(10):1562-1574.
|
11. |
Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am, 2012, 41(3):595-611.
|
12. |
Mehan MR, Ostroff R, Wilcox SK, et al. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics. Adv Exp Med Biol, 2013, 735:283-300.
|
13. |
Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head:a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol, 2009, 114(3-5):121-128.
|
14. |
O'Brien MA, Costin BN, Miles MF. Using genome-wide expression profiling to define gene networks relevant to the study of complex traits:from RNA integrity to network topology. Int Rev Neurobiol, 2012, 104:91-133.
|
15. |
Zehner M, Burgdorf S. Regulation of antigen transport into the cytosol for cross-presentation by ubiquitination of the mannose receptor. Mol Immunol, 2013, 55(2):146-148.
|
16. |
Morris CR, Stanton MJ, Manthey KC, et al. A knockout of the Tsg101 gene leads to decreased expression of ErbB receptor tyrosine kinases and induction of autophagy prior to cell death. PLoS One, 2012, 7(3):e34308.
|
17. |
Gruenberg J. Viruses and endosome membrane dynamics. Curr Opin Cell Biol, 2009, 21(4):582-588.
|
18. |
Wagner SA, Beli P, Weinert BT, et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics, 2011, 10(10):M111.
|
19. |
Ma XR, Edmund Sim UH, Pauline B, et al. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma. Trop Biomed, 2008, 25(1):46-57.
|
20. |
Shen J, Abel EL, Riggs PK, et al. Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice. Carcinogenesis, 2012, 33(11):2208-2219.
|
21. |
杨雨润, 娄晋宁, 李子荣, 等. 糖皮质激素对骨髓微血管内皮细胞活性氧代谢影响的实验研究. 中国修复重建外科杂志, 2011, 25(5):533-537.
|
22. |
Winbanks CE, Chen JL, Qian H, et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol, 2013, 203(2):345-357.
|
23. |
Grönroos E, Kingston IJ, Ramachandran A, et al. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol, 2012, 32(14):2904-2916.
|
24. |
Yang J, Li X, Al-Lamki RS, et al. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res, 2010, 107(2):252-262.
|
25. |
Emes Y, Aybar B, Vural P, et al. Effects of bone morphogenetic proteins on osteoblast cells:vascular endothelial growth factor, calcium, inorganic phosphate, and nitric oxide levels. Implant Dent, 2010, 19(5):419-427.
|
26. |
Tang Y, Yang X, Friesel RE, et al. Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells. J Vasc Res, 2011, 48(6):485-494.
|